{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T14:43:03Z","timestamp":1785595383833,"version":"3.56.0"},"reference-count":134,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.pharmthera.2023.108468","type":"journal-article","created":{"date-parts":[[2023,6,6]],"date-time":"2023-06-06T01:58:02Z","timestamp":1686016682000},"page":"108468","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Potential neonatal toxicity of new psychoactive substances"],"prefix":"10.1016","volume":"248","author":[{"given":"Ryoichi","family":"Fujiwara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Journey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatimah","family":"Al-Doori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paris","family":"Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brahmjot","family":"Judge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamille","family":"Miracle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kousei","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.pharmthera.2023.108468_bb0005","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1056\/NEJMoa1610300","article-title":"\u201cZombie\u201d outbreak caused by the synthetic cannabinoid AMB-FUBINACA in New York","volume":"376","author":"Adams","year":"2017","journal-title":"The New England Journal of Medicine"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108468_bb0010","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/ijnp\/pyy003","article-title":"Adolescent synthetic cannabinoid exposure produces enduring changes in dopamine neuron activity in a rodent model of schizophrenia susceptibility","volume":"21","author":"Aguilar","year":"2018","journal-title":"The International Journal of Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108468_bb0015","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1124\/jpet.102.038315","article-title":"Transporter gene expression in lactating and nonlactating human mammary epithelial cells using real-time reverse transcription-polymerase chain reaction","volume":"303","author":"Alcorn","year":"2002","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"issue":"6","key":"10.1016\/j.pharmthera.2023.108468_bb0020","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.682","article-title":"Diversity of molecular targets and signaling pathways for CBD","volume":"8","author":"de Almeida","year":"2020","journal-title":"Pharmacology Research & Perspectives"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108468_bb0025","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2018-2690","article-title":"Neuropsychiatric sequelae in adolescents with acute synthetic cannabinoid toxicity","volume":"144","author":"Anderson","year":"2019","journal-title":"Pediatrics"},{"key":"10.1016\/j.pharmthera.2023.108468_bb0030","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.taap.2017.02.004","article-title":"Potential transfer of neurotoxic amino acid \u03b2-N-methylamino-alanine (BMAA) from mother to infant during breast-feeding: Predictions from human cell lines","volume":"320","author":"Andersson","year":"2017","journal-title":"Toxicology and Applied Pharmacology"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108468_bb0035","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/j.1365-2125.1988.tb03334.x","article-title":"Prediction of drug concentrations in human skim milk from plasma protein binding and acid-base characteristics","volume":"25","author":"Atkinson","year":"1988","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1016\/j.pharmthera.2023.108468_bb0040","series-title":"Novel psychoactive substances","first-page":"317","article-title":"Synthetic cannabinoid receptor agonists","author":"Auw\u00e4rter","year":"2013"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108468_bb0045","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1365-2125.1992.tb04077.x","article-title":"Prospective evaluation of a model for the prediction of milk:Plasma drug concentrations from physicochemical characteristics","volume":"33","author":"Begg","year":"1992","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1016\/j.pharmthera.2023.108468_bb0050","first-page":"1002","article-title":"Synthetic cannabinoid and synthetic cocaine use during pregnancy in a soldier","volume":"1","author":"Berry-Cab\u00e1n","year":"2013","journal-title":"Journal of Substance Abuse and Alcoholism"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108468_bb0055","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/bcpt.12392","article-title":"Expression of CYP3A4 and CYP3A7 in human foetal tissues and its correlation with nuclear receptors","volume":"117","author":"Betts","year":"2015","journal-title":"Basic & Clinical Pharmacology & Toxicology"},{"key":"10.1016\/j.pharmthera.2023.108468_bb0060","doi-asserted-by":"crossref","first-page":"17","DOI":"10.4137\/PMC.S32171","article-title":"The structure-function relationships of classical cannabinoids: CB1\/CB2 modulation","volume":"8","author":"Bow","year":"2016","journal-title":"Perspectives in Medicinal Chemistry"},{"issue":"7","key":"10.1016\/j.pharmthera.2023.108468_bb0065","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.bcp.2012.01.004","article-title":"Monohydroxylated metabolites of the K2 synthetic cannabinoid JWH-073 retain intermediate to high cannabinoid 1 receptor (CB1R) affinity and exhibit neutral antagonist to partial agonist activity","volume":"83","author":"Brents","year":"2012","journal-title":"Biochemical Pharmacology"},{"issue":"7","key":"10.1016\/j.pharmthera.2023.108468_bb0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0021917","article-title":"Phase I hydroxylated metabolites of the K2 synthetic cannabinoid JWH-018 retain in vitro and in vivo cannabinoid 1 receptor affinity and activity","volume":"6","author":"Brents","year":"2011","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108468_bb0075","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.janh.2017.02.001","article-title":"The chemical history of morphine: An 8000-year journey, from resin to de-novo synthesis","volume":"3","author":"Brook","year":"2017","journal-title":"Journal of Anesthesia History"},{"key":"10.1016\/j.pharmthera.2023.108468_bb0080","series-title":"The CBHSQ report","first-page":"1","article-title":"Update: Drug-related The CBHSQ reportemergency department visits involving synthetic cannabinoids","author":"Bush","year":"2014"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108468_bb0085","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1521-0391.2009.00022.x","article-title":"Sex under the influence of drugs or alcohol: Common for men in substance abuse treatment and associated with high-risk sexual behavior","volume":"19","author":"Calsyn","year":"2010","journal-title":"The American Journal on Addictions"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108468_bb0090","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/FTD.0000000000000667","article-title":"Monitoring perinatal exposure to cannabis and synthetic cannabinoids","volume":"42","author":"Carlier","year":"2020","journal-title":"Therapeutic Drug Monitoring"},{"issue":"6","key":"10.1016\/j.pharmthera.2023.108468_bb0095","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/dta.1709","article-title":"Quantitative urine confirmatory testing for synthetic cannabinoids in randomly collected urine specimens","volume":"7","author":"Castaneto","year":"2015","journal-title":"Drug Testing and Analysis"},{"key":"10.1016\/j.pharmthera.2023.108468_bb0100","first-page":"1","article-title":"Mechanisms of action and pharmacokinetics of cannabis","volume":"25","author":"Chayasirisobhon","year":"2020","journal-title":"The Permanente Journal"},{"key":"10.1016\/j.pharmthera.2023.108468_bb0105","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12889-015-2627-z","article-title":"Substance use patterns and unprotected sex among street-involved youth in a Canadian setting: A prospective cohort study","volume":"16","author":"Cheng","year":"2016","journal-title":"BMC Public Health"},{"issue":"11","key":"10.1016\/j.pharmthera.2023.108468_bb0110","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1124\/dmd.112.047530","article-title":"Cytochrome P450-mediated oxidative metabolism of abused synthetic cannabinoids found in K2\/spice: Identification of novel cannabinoid receptor ligands","volume":"40","author":"Chimalakonda","year":"2012","journal-title":"Drug Metabolism and Disposition"},{"issue":"13","key":"10.1016\/j.pharmthera.2023.108468_bb0115","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1056\/NEJMe1810418","article-title":"Hemorrhagic highs from synthetic cannabinoids - a new epidemic","volume":"379","author":"Connors","year":"2018","journal-title":"The New England Journal of Medicine"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108468_bb0120","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s11920-016-0694-1","article-title":"Adverse effects of synthetic cannabinoids: Management of acute toxicity and withdrawal","volume":"18","author":"Cooper","year":"2016","journal-title":"Current Psychiatry Reports"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108468_bb0125","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s11419-021-00606-6","article-title":"Phase I-metabolism studies of the synthetic cannabinoids PX-1 and PX-2 using three different in vitro models","volume":"40","author":"Dahm","year":"2022","journal-title":"Forensic Toxicology"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108468_bb0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/jpm8010001","article-title":"Pharmacogenomics of CYP2C9: Functional and clinical considerations","volume":"8","author":"Daly","year":"2017","journal-title":"Journal of Personalized Medicine"},{"issue":"18","key":"10.1016\/j.pharmthera.2023.108468_bb0135","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1002\/rcm.6673","article-title":"In vivo and in vitro metabolism of the synthetic cannabinoid JWH-200","volume":"27","author":"De Brabanter","year":"2013","journal-title":"Rapid Communications in Mass Spectrometry: RCM"},{"key":"10.1016\/j.pharmthera.2023.108468_bb0140","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s11419-016-0312-2","article-title":"Strategies to distinguish new synthetic cannabinoid FUBIMINA (BIM-2201) intake from its isomer THJ-2201: Metabolism of FUBIMINA in human hepatocytes","volume":"34","author":"Diao","year":"2016","journal-title":"Forensic Toxicology"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108468_bb0145","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3109\/03602532.2015.1137307","article-title":"Metabolomics of \u03949-tetrahydrocannabinol: Implications in toxicity","volume":"48","author":"Dinis-Oliveira","year":"2016","journal-title":"Drug Metabolism Reviews"},{"issue":"6","key":"10.1016\/j.pharmthera.2023.108468_bb0150","doi-asserted-by":"crossref","first-page":"e355","DOI":"10.1097\/PEC.0000000000001492","article-title":"Unintentional exposure of an infant to synthetic cannabinoid (Bonzai) related to the Parent\u2019s use","volume":"36","author":"Dinleyici","year":"2020","journal-title":"Pediatric Emergency Care"},{"issue":"12","key":"10.1016\/j.pharmthera.2023.108468_bb0155","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1002\/jcc.540141208","article-title":"Estimation of pKa for organic oxyacids using calculated atomic charges","volume":"14","author":"Dixon","year":"1993","journal-title":"Journal of Computational Chemistry"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108468_bb0160","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s00018-018-2955-0","article-title":"Cannabinoid exposure during pregnancy and its impact on immune function","volume":"76","author":"Dong","year":"2019","journal-title":"Cellular and Molecular Life Sciences"},{"issue":"10","key":"10.1016\/j.pharmthera.2023.108468_bb0165","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1021\/acschemneuro.8b00117","article-title":"DARK classics in chemical neuroscience: Cocaine","volume":"9","author":"Drake","year":"2018","journal-title":"ACS Chemical Neuroscience"},{"issue":"8","key":"10.1016\/j.pharmthera.2023.108468_bb0170","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1038\/sj.npp.1300496","article-title":"The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: Implications for psychosis","volume":"29","author":"D\u2019Souza","year":"2004","journal-title":"Neuropsychopharmacology"},{"issue":"1\u20133","key":"10.1016\/j.pharmthera.2023.108468_bb0175","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.forsciint.2012.09.010","article-title":"Identification, extraction and quantification of the synthetic cannabinoid JWH-018 from commercially available herbal marijuana alternatives","volume":"223","author":"Dunham","year":"2012","journal-title":"Forensic Science International"},{"key":"10.1016\/j.pharmthera.2023.108468_bb0180","series-title":"High-risk drug use and new psychoactive substances. EMCDDA Rapid Communication","author":"European Monitoring Centre for Drugs and Drug Addiction","year":"2017"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108468_bb0185","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/clpt.1981.87","article-title":"Analgesic drugs in breast milk and plasma","volume":"29","author":"Findlay","year":"1981","journal-title":"Clinical Pharmacology and Therapeutics"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108468_bb0190","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1111\/j.1465-7295.2012.00506.x","article-title":"Measuring crack cocaine and its impact","volume":"51","author":"Fryer","year":"2013","journal-title":"Economic Inquiry"},{"issue":"8","key":"10.1016\/j.pharmthera.2023.108468_bb0195","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/hep4.1082","article-title":"Severe neonatal hyperbilirubinemia in Crigler-Najjar syndrome model mice can be reversed with zinc Protoporphyrin","volume":"1","author":"Fujiwara","year":"2017","journal-title":"Hepatology Communications"},{"issue":"11","key":"10.1016\/j.pharmthera.2023.108468_bb0200","doi-asserted-by":"crossref","first-page":"5024","DOI":"10.1073\/pnas.0913290107","article-title":"Developmental hyperbilirubinemia and CNS toxicity in mice humanized with the UDP glucuronosyltransferase 1 (UGT1) locus","volume":"107","author":"Fujiwara","year":"2010","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108468_bb0205","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1111\/j.1365-2125.2012.04363.x","article-title":"A pregnancy physiologically based pharmacokinetic (p-PBPK) model for disposition of drugs metabolized by CYP1A2, CYP2D6 and CYP3A4","volume":"74","author":"Gaohua","year":"2012","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1016\/j.pharmthera.2023.108468_bb0210","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ntt.2015.12.004","article-title":"Dose-dependent teratogenicity of the synthetic cannabinoid CP-55,940 in mice","volume":"58","author":"Gilbert","year":"2016","journal-title":"Neurotoxicology and Teratology"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108468_bb0215","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.yhbeh.2009.08.009","article-title":"Male-female differences in the effects of cannabinoids on sexual behavior and gonadal hormone function","volume":"58","author":"Gorzalka","year":"2010","journal-title":"Hormones and Behavior"},{"key":"10.1016\/j.pharmthera.2023.108468_bb0220","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.chroma.2012.08.085","article-title":"Micellar electrokinetic chromatography: A new simple tool for the analysis of synthetic cannabinoids in herbal blends and for the rapid estimation of their logP values","volume":"1267","author":"Gottardo","year":"2012","journal-title":"Journal of Chromatography. A"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108468_bb0225","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.pharma.2008.07.006","article-title":"Pharmacocin\u00e9tique du delta-9-t\u00e9trahydrocannabinol (THC) [Delta-9-tetrahydrocannabinol pharmacokinetics]","volume":"66","author":"Goull\u00e9","year":"2008","journal-title":"Annales Pharmaceutiques Fran\u00e7aises"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108468_bb0230","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.mcna.2018.02.010","article-title":"New and emerging illicit psychoactive substances","volume":"102","author":"Graddy","year":"2018","journal-title":"The Medical Clinics of North America"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108468_bb0235","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2165\/00003088-200342040-00003","article-title":"Pharmacokinetics and pharmacodynamics of cannabinoids","volume":"42","author":"Grotenhermen","year":"2003","journal-title":"Clinical Pharmacokinetics"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108468_bb0240","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2174\/1389200043489199","article-title":"The MRP-related and BCRP\/ABCG2 multidrug resistance proteins: Biology, substrate specificity and regulation","volume":"5","author":"Haimeur","year":"2004","journal-title":"Current Drug Metabolism"},{"issue":"12","key":"10.1016\/j.pharmthera.2023.108468_bb0245","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1001\/jamapsychiatry.2015.1858","article-title":"Prevalence of marijuana use disorders in the United States between 2001-2002 and 2012-2013","volume":"72","author":"Hasin","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.pharmthera.2023.108468_bb0250","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/1471-2105-14-130","article-title":"Predicting substrates of the human breast cancer resistance protein using a support vector machine method","volume":"14","author":"Hazai","year":"2013","journal-title":"BMC Bioinformatics"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108468_bb0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/15563650.2016.1217003","article-title":"New psychoactive substances (NPS) - the Hydra monster of recreational drugs","volume":"55","author":"Helander","year":"2017","journal-title":"Clinical Toxicology (Philadelphia, Pa.)"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108468_bb0260","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/sj.bjp.0707467","article-title":"The multidrug transporter ABCG2 (BCRP) is inhibited by plant-derived cannabinoids","volume":"152","author":"Holland","year":"2007","journal-title":"British Journal of Pharmacology"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108468_bb0265","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/dta.1663","article-title":"Metabolites of 5F-AKB-48, a synthetic cannabinoid receptor agonist, identified in human urine and liver microsomal preparations using liquid chromatography high-resolution mass spectrometry","volume":"7","author":"Holm","year":"2015","journal-title":"Drug Testing and Analysis"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108468_bb0270","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/jat\/16.5.276","article-title":"Blood cannabinoids. I. Absorption of THC and formation of 11-OH-THC and THCCOOH during and after smoking marijuana","volume":"16","author":"Huestis","year":"1992","journal-title":"Journal of Analytical Toxicology"},{"issue":"20","key":"10.1016\/j.pharmthera.2023.108468_bb0275","doi-asserted-by":"crossref","first-page":"3875","DOI":"10.1021\/jm960394y","article-title":"Synthesis and pharmacology of a very potent cannabinoid lacking a phenolic hydroxyl with high affinity for the CB2 receptor","volume":"39","author":"Huffman","year":"1996","journal-title":"Journal of Medicinal Chemistry"},{"issue":"7","key":"10.1016\/j.pharmthera.2023.108468_bb0280","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1002\/jms.3229","article-title":"Characteristics of the designer drug and synthetic cannabinoid receptor agonist AM-2201 regarding its chemistry and metabolism","volume":"48","author":"Hutter","year":"2013","journal-title":"Journal of Mass Spectrometry: JMS"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108468_bb0285","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1093\/jat\/bkz092","article-title":"Case report: Synthetic cannabinoid deaths in state of Florida prisoners","volume":"44","author":"Hvozdovich","year":"2020","journal-title":"Journal of Analytical Toxicology"},{"issue":"10","key":"10.1016\/j.pharmthera.2023.108468_bb0290","doi-asserted-by":"crossref","first-page":"3342","DOI":"10.1002\/jps.24138","article-title":"Organic cation transporter\/solute carrier family 22a is involved in drug transfer into milk in mice","volume":"103","author":"Ito","year":"2014","journal-title":"Journal of Pharmaceutical Sciences"},{"issue":"8","key":"10.1016\/j.pharmthera.2023.108468_bb0295","first-page":"2527","article-title":"Prediction of drug transfer into milk considering breast cancer resistance protein (BCRP)-mediated transport","volume":"32","author":"Ito","year":"2015","journal-title":"Pharmaceutical Research"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108468_bb0300","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S0169-409X(03)00031-0","article-title":"Xenobiotic transporter expression and function in the human mammary gland","volume":"55","author":"Ito","year":"2003","journal-title":"Advanced Drug Delivery Reviews"},{"key":"10.1016\/j.pharmthera.2023.108468_bb0305","series-title":"The science of marijuana","author":"Iversen","year":"2008"},{"key":"10.1016\/j.pharmthera.2023.108468_bb0310","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.forsciint.2014.08.008","article-title":"Determination of major metabolites of MAM-2201 and JWH-122 in in vitro and in vivo studies to distinguish their intake","volume":"244","author":"Jang","year":"2014","journal-title":"Forensic Science International"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108468_bb0315","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.1042","article-title":"Prediction of milk plasma ratio for amphoteric substances","volume":"11","author":"Jones","year":"2023","journal-title":"Pharmacology Research & Perspectives"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108468_bb0320","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.561","article-title":"Identifying cytochrome P450s involved in oxidative metabolism of synthetic cannabinoid N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide (STS-135)","volume":"8","author":"Jones","year":"2020","journal-title":"Pharmacology Research & Perspectives"},{"issue":"12","key":"10.1016\/j.pharmthera.2023.108468_bb0325","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1080\/00498254.2019.1580403","article-title":"Enzymatic analysis of glucuronidation of synthetic cannabinoid 1-naphthyl 1-(4-fluorobenzyl)-1H-indole-3-carboxylate (FDU-PB-22)","volume":"49","author":"Jones","year":"2019","journal-title":"Xenobiotica"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108468_bb0330","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/nm1186","article-title":"The breast cancer resistance protein BCRP (ABCG2) concentrates drugs and carcinogenic xenotoxins into milk","volume":"11","author":"Jonker","year":"2005","journal-title":"Nature Medicine"},{"issue":"7","key":"10.1016\/j.pharmthera.2023.108468_bb0335","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1093\/anatox\/35.7.386","article-title":"Development and validation of a liquid chromatography-tandem mass spectrometry method for the identification and quantification of JWH-018, JWH-073, JWH-019, and JWH-250 in human whole blood","volume":"35","author":"Kacinko","year":"2011","journal-title":"Journal of Analytical Toxicology"},{"issue":"43","key":"10.1016\/j.pharmthera.2023.108468_bb0340","doi-asserted-by":"crossref","first-page":"29817","DOI":"10.1074\/jbc.M109.050187","article-title":"Atypical responsiveness of the orphan receptor GPR55 to cannabinoid ligands","volume":"284","author":"Kapur","year":"2009","journal-title":"The Journal of Biological Chemistry"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108468_bb0345","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1080\/15563650.2018.1485927","article-title":"Severe illness associated with reported use of synthetic cannabinoids: A public health investigation (Mississippi, 2015)","volume":"57","author":"Kasper","year":"2019","journal-title":"Clinical Toxicology (Philadelphia, Pa.)"},{"key":"10.1016\/j.pharmthera.2023.108468_bb0350","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.drugalcdep.2016.07.018","article-title":"Age, period, and cohort effects in synthetic cannabinoid use among US adolescents, 2011-2015","volume":"166","author":"Keyes","year":"2016","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.pharmthera.2023.108468_bb0355","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.655320","article-title":"Pregnancy-related hormones increase UGT1A1-mediated labetalol metabolism in human hepatocytes","volume":"12","author":"Khatri","year":"2021","journal-title":"Frontiers in Pharmacology"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108468_bb0360","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.xphs.2020.09.013","article-title":"Pregnancy-related hormones increase Nifedipine metabolism in human hepatocytes by inducing CYP3A4 expression","volume":"110","author":"Khatri","year":"2021","journal-title":"Journal of Pharmaceutical Sciences"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108468_bb0365","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/BF02968594","article-title":"Development of a human mammary epithelial cell culture model for evaluation of drug transfer into milk","volume":"29","author":"Kimura","year":"2006","journal-title":"Archives of Pharmacal Research"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108468_bb0370","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1021\/ci00020a009","article-title":"Computer automated log P calculations based on an extended group contribution approach","volume":"34","author":"Klopman","year":"1994","journal-title":"Journal of Chemical Information and Computer Sciences"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108468_bb0375","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1124\/dmd.110.035790","article-title":"Altered cytochrome P450 expression in mice during pregnancy","volume":"39","author":"Koh","year":"2011","journal-title":"Drug Metabolism and Disposition"},{"issue":"25","key":"10.1016\/j.pharmthera.2023.108468_bb0380","first-page":"425","article-title":"Brain development during adolescence: Neuroscientific insights into this developmental period","volume":"110","author":"Konrad","year":"2013","journal-title":"Deutsches \u00c4rzteblatt International"},{"key":"10.1016\/j.pharmthera.2023.108468_bb0385","article-title":"Utilizing public and private sector data to build better machine learning models for the prediction of pharmacokinetic parameters","volume":"103339","author":"Kuroda","year":"2022","journal-title":"Drug Discovery Today"},{"issue":"7","key":"10.1016\/j.pharmthera.2023.108468_bb0390","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1124\/dmd.114.057083","article-title":"Glucuronidation of drugs and drug-induced toxicity in humanized UDP-glucuronosyltransferase 1 mice","volume":"42","author":"Kutsuno","year":"2014","journal-title":"Drug Metabolism and Disposition"},{"issue":"8","key":"10.1016\/j.pharmthera.2023.108468_bb0395","doi-asserted-by":"crossref","first-page":"760","DOI":"10.3109\/15563650.2011.609822","article-title":"Severe toxicity following synthetic cannabinoid ingestion","volume":"49","author":"Lapoint","year":"2011","journal-title":"Clinical Toxicology (Philadelphia, Pa.)"},{"issue":"9","key":"10.1016\/j.pharmthera.2023.108468_bb0400","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1345\/aph.1C379","article-title":"Prediction of milk\/plasma concentration ratio of drugs","volume":"37","author":"Larsen","year":"2003","journal-title":"The Annals of Pharmacotherapy"},{"issue":"22","key":"10.1016\/j.pharmthera.2023.108468_bb0405","first-page":"618","article-title":"Notes from the field: Increase in reported adverse health effects related to synthetic cannabinoid use - United States, January-May 2015","volume":"64","author":"Law","year":"2015","journal-title":"MMWR. Morbidity and Mortality Weekly Report"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108468_bb0410","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1124\/jpet.105.086504","article-title":"Variability of CYP3A7 expression in human fetal liver","volume":"314","author":"Leeder","year":"2005","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2023.108468_bb0415","doi-asserted-by":"crossref","DOI":"10.1016\/j.legalmed.2022.102086","article-title":"A retrospective analysis of data from illicit drug abuse cases in Beijing between 2018 and 2020","volume":"58","author":"Li","year":"2022","journal-title":"Legal Medicine (Tokyo, Japan)"},{"issue":"7","key":"10.1016\/j.pharmthera.2023.108468_bb0420","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.drudis.2018.03.002","article-title":"Prediction of brain: Blood unbound concentration ratios in CNS drug discovery employing in silico and in vitro model systems","volume":"23","author":"Liu","year":"2018","journal-title":"Drug Discovery Today"},{"issue":"9","key":"10.1016\/j.pharmthera.2023.108468_bb0425","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.7205\/MILMED-D-12-00180","article-title":"Spice, bath salts, and the U.S. military: The emergence of synthetic cannabinoid receptor agonists and cathinones in the U.S. armed forces","volume":"177","author":"Loeffler","year":"2012","journal-title":"Military Medicine"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108468_bb0430","doi-asserted-by":"crossref","first-page":"262","DOI":"10.5863\/1551-6776-19.4.262","article-title":"Developmental pharmacokinetics in pediatric populations","volume":"19","author":"Lu","year":"2014","journal-title":"The Journal of Pediatric Pharmacology and Therapeutics"},{"issue":"11","key":"10.1016\/j.pharmthera.2023.108468_bb0435","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1111\/bcp.13710","article-title":"The pharmacokinetics and the pharmacodynamics of cannabinoids","volume":"84","author":"Lucas","year":"2018","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1016\/j.pharmthera.2023.108468_bb0440","doi-asserted-by":"crossref","DOI":"10.1002\/dta.2387","article-title":"Experimental versus theoretical log D7.4, pKa and plasma protein binding values for benzodiazepines appearing as new psychoactive substances","author":"Manchester","year":"2018","journal-title":"Drug Testing and Analysis"},{"issue":"10","key":"10.1016\/j.pharmthera.2023.108468_bb0445","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1002\/dta.1938","article-title":"Toxicokinetics of new psychoactive substances: Plasma protein binding, metabolic stability, and human phase I metabolism of the synthetic cannabinoid WIN 55,212-2 studied using in vitro tools and LC-HR-MS\/MS","volume":"8","author":"Mardal","year":"2016","journal-title":"Drug Testing and Analysis"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108468_bb0450","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jsat.2014.07.007","article-title":"Recent trends in treatment admissions for prescription opioid abuse during pregnancy","volume":"48","author":"Martin","year":"2015","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"6","key":"10.1016\/j.pharmthera.2023.108468_bb0455","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1111\/j.1365-2125.1990.tb05443.x","article-title":"Midazolam and nitrazepam in the maternity ward: Milk concentrations and clinical effects","volume":"30","author":"Matheson","year":"1990","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"10","key":"10.1016\/j.pharmthera.2023.108468_bb0460","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1248\/bpb.b16-00195","article-title":"Acyl-glucuronide as a possible cause of trovafloxacin-induced liver toxicity: Induction of chemokine (C-X-C motif) ligand 2 by Trovafloxacin acyl-glucuronide","volume":"39","author":"Mitsugi","year":"2016","journal-title":"Biological & Pharmaceutical Bulletin"},{"issue":"11","key":"10.1016\/j.pharmthera.2023.108468_bb0465","doi-asserted-by":"crossref","first-page":"4228","DOI":"10.1021\/ac2005636","article-title":"Quantitative measurement of JWH-018 and JWH-073 metabolites excreted in human urine","volume":"83","author":"Moran","year":"2011","journal-title":"Analytical Chemistry"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108468_bb0470","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/scientificamerican0791-40","article-title":"Opium, cocaine and marijuana in American history, USA","volume":"265","author":"Musto","year":"1991","journal-title":"Scientific American"},{"key":"10.1016\/j.pharmthera.2023.108468_bb0475","author":"National Center for Health Statistics"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108468_bb0480","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/dta.2697","article-title":"Simultaneous analysis of 29 synthetic cannabinoids and metabolites, amphetamines, and cannabinoids in human whole blood by liquid chromatography-tandem mass spectrometry - a New Zealand perspective of use in 2018","volume":"12","author":"Ong","year":"2020","journal-title":"Drug Testing and Analysis"},{"issue":"7","key":"10.1016\/j.pharmthera.2023.108468_bb0485","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1016\/j.xphs.2016.04.023","article-title":"Development of a support vector machine-based system to predict whether a compound is a substrate of a given drug transporter using its chemical structure","volume":"105","author":"Ose","year":"2016","journal-title":"Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.pharmthera.2023.108468_bb0490","doi-asserted-by":"crossref","first-page":"S612","DOI":"10.1016\/S0924-977X(15)30865-8","article-title":"P. 6. d. 003 baby bonzai: A case of maternal exposure to synthetic cannabinoid during pregnancy","volume":"25","author":"Ozt\u00fcrk","year":"2015","journal-title":"European Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2023.108468_bb0495","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.drugalcdep.2015.01.044","article-title":"Synthetic cannabinoid use in a nationally representative sample of US high school seniors","volume":"149","author":"Palamar","year":"2015","journal-title":"Drug and Alcohol Dependence"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108468_bb0500","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.bbrc.2018.03.028","article-title":"Altered metabolism of synthetic cannabinoid JWH-018 by human cytochrome P450 2C9 and variants","volume":"498","author":"Patton","year":"2018","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108468_bb0505","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/sj.bjp.0707442","article-title":"The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin","volume":"153","author":"Pertwee","year":"2008","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2023.108468_bb0510","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2020.172949","article-title":"Metabolism, CB1 cannabinoid receptor binding and in vivo activity of synthetic cannabinoid 5F-AKB48: Implications for toxicity","volume":"195","author":"Pinson","year":"2020","journal-title":"Pharmacology, Biochemistry, and Behavior"},{"issue":"8","key":"10.1016\/j.pharmthera.2023.108468_bb0515","doi-asserted-by":"crossref","first-page":"509","DOI":"10.3390\/metabo11080509","article-title":"In vitro metabolic fate of the synthetic cannabinoid receptor agonists QMPSB and QMPCB (SGT-11) including isozyme mapping and esterase activity","volume":"11","author":"Richter","year":"2021","journal-title":"Metabolites"},{"key":"10.1016\/j.pharmthera.2023.108468_bb0520","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.placenta.2020.07.009","article-title":"Differences in cytochrome p450 enzyme expression and activity in fetal and adult tissues","volume":"100","author":"Robinson","year":"2020","journal-title":"Placenta"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108468_bb0525","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2021-050888","article-title":"Near-fatal spice intoxication of a toddler","volume":"148","author":"Ruiz-Maldonado","year":"2021","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.pharmthera.2023.108468_bb0535","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S0026-895X(24)05627-X","volume":"66","author":"Sasaki","year":"2004","journal-title":"Molecular Pharmacology"},{"key":"10.1016\/j.pharmthera.2023.108468_bb0540","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.toxlet.2016.04.021","article-title":"Pharmacokinetics of (synthetic) cannabinoids in pigs and their relevance for clinical and forensic toxicology","volume":"253","author":"Schaefer","year":"2016","journal-title":"Toxicology Letters"},{"issue":"11","key":"10.1016\/j.pharmthera.2023.108468_bb0545","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1002\/cbdv.200900171","article-title":"Transporters in absorption, distribution, and elimination","volume":"6","author":"Scherrmann","year":"2009","journal-title":"Chemistry & Biodiversity"},{"issue":"4","key":"10.1016\/j.pharmthera.2023.108468_bb0550","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1021\/tx3000472","article-title":"A major glucuronidated metabolite of JWH-018 is a neutral antagonist at CB1 receptors","volume":"25","author":"Seely","year":"2012","journal-title":"Chemical Research in Toxicology"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108468_bb0555","doi-asserted-by":"crossref","first-page":"97S","DOI":"10.1097\/01.AOG.0000514958.58005.54","article-title":"A synthetic cannabinoid use in pregnancy: A brief educational intervention for obstetric providers and patients [19I]","volume":"129","author":"Sellers","year":"2017","journal-title":"Obstetrics & Gynecology"},{"issue":"7","key":"10.1016\/j.pharmthera.2023.108468_bb0560","doi-asserted-by":"crossref","first-page":"668","DOI":"10.3390\/ph14070668","article-title":"Pharmacokinetic properties of the novel synthetic cannabinoid 5F-APINAC and its influence on metabolites associated with neurotransmission in rabbit plasma","volume":"14","author":"Shestakova","year":"2021","journal-title":"Pharmaceuticals (Basel, Switzerland)"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108468_bb0565","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s11419-016-0346-5","article-title":"Headspace solid-phase microextraction and gas chromatography\u2212 mass spectrometry for determination of cannabinoids in human breast milk","volume":"35","author":"Silveira","year":"2017","journal-title":"Forensic Toxicology"},{"issue":"8","key":"10.1016\/j.pharmthera.2023.108468_bb0570","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1002\/cbdv.200790149","article-title":"Medicinal chemistry endeavors around the phytocannabinoids","volume":"4","author":"Stern","year":"2007","journal-title":"Chemistry & Biodiversity"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108468_bb0575","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40352-015-0015-5","article-title":"Pregnant women and substance use: Fear, stigma, and barriers to care","volume":"3","author":"Stone","year":"2015","journal-title":"Health & Justice"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108468_bb0580","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1136\/gut.50.2.259","article-title":"Developmental aspects of human hepatic drug glucuronidation in young children and adults","volume":"50","author":"Strassburg","year":"2002","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108468_bb0585","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.lfs.2013.06.018","article-title":"Synthetic cannabinoids and potential reproductive consequences","volume":"97","author":"Sun","year":"2014","journal-title":"Life Sciences"},{"issue":"9\u201310","key":"10.1016\/j.pharmthera.2023.108468_bb0590","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.drudis.2007.12.010","article-title":"The role of ABC transporters in drug absorption, distribution, metabolism, excretion and toxicity (ADME\u2013Tox)","volume":"13","author":"Szak\u00e1cs","year":"2008","journal-title":"Drug Discovery Today"},{"key":"10.1016\/j.pharmthera.2023.108468_bb0595","first-page":"48","article-title":"Marijuana: Prenatal and postnatal exposure in the human","volume":"59","author":"Tennes","year":"1985","journal-title":"NIDA Research Monograph"},{"issue":"27","key":"10.1016\/j.pharmthera.2023.108468_bb0600","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1016\/j.jchromb.2010.03.016","article-title":"Sensitive and rapid quantification of the cannabinoid receptor agonist naphthalen-1-yl-(1-pentylindol-3-yl)methanone (JWH-018) in human serum by liquid chromatography-tandem mass spectrometry","volume":"878","author":"Teske","year":"2010","journal-title":"Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences"},{"issue":"14","key":"10.1016\/j.pharmthera.2023.108468_bb0605","doi-asserted-by":"crossref","first-page":"8030","DOI":"10.3390\/ijms23148030","article-title":"In vivo bio-activation of JWH-175 to JWH-018: Pharmacodynamic and pharmacokinetic studies in mice","volume":"23","author":"Tirri","year":"2022","journal-title":"International Journal of Molecular Sciences"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108468_bb0610","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0022-3565(24)36459-6","article-title":"Active transport of nitrofurantoin across a mouse mammary epithelial monolayer","volume":"280","author":"Toddywalla","year":"1997","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108468_bb0615","first-page":"9168","article-title":"Identification of cytochrome P450 enzymes responsible for oxidative metabolism of synthetic cannabinoid (1-hexyl-1H-indol-3-yl)-1-naphthalenyl-methanone (JWH-019)","volume":"86","author":"Tran","year":"2022","journal-title":"American Journal of Pharmaceutical Education"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108468_bb0620","doi-asserted-by":"crossref","first-page":"e118","DOI":"10.1097\/MJT.0000000000000909","article-title":"A new safety scoring system for the use of psychotropic drugs during lactation","volume":"28","author":"Uguz","year":"2021","journal-title":"American Journal of Therapeutics"},{"key":"10.1016\/j.pharmthera.2023.108468_bb0625","series-title":"Early warning advisory on new psychoactive substances - What are NSPs?","author":"United Nations Office on Drugs and Crime","year":"2020"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108468_bb0630","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1086\/SHAD3201038","article-title":"The land of narcotics: Depictions of U.S. abuse of morphine, heroin and cocaine in Dutch 1920 newspapers","volume":"32","author":"Walma","year":"2018","journal-title":"The Social History of Alcohol and Drugs"},{"key":"10.1016\/j.pharmthera.2023.108468_bb0635","series-title":"Synthetic cannabinoids: Acute intoxication","author":"Wang","year":"2015"},{"issue":"1","key":"10.1016\/j.pharmthera.2023.108468_bb0640","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1749-6632.1982.tb39469.x","article-title":"History of opiate use in the orient and the United States","volume":"398","author":"Way","year":"1982","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"5","key":"10.1016\/j.pharmthera.2023.108468_bb0645","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1007\/s00216-010-4171-0","article-title":"In vitro phase I metabolism of the synthetic cannabimimetic JWH-018","volume":"398","author":"Wintermeyer","year":"2010","journal-title":"Analytical and Bioanalytical Chemistry"},{"issue":"6","key":"10.1016\/j.pharmthera.2023.108468_bb0650","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1007\/s00216-014-7668-0","article-title":"Metabolism of synthetic cannabinoids PB-22 and its 5-fluoro analog, 5F-PB-22, by human hepatocyte incubation and high-resolution mass spectrometry","volume":"406","author":"Wohlfarth","year":"2014","journal-title":"Analytical and Bioanalytical Chemistry"},{"issue":"6","key":"10.1016\/j.pharmthera.2023.108468_bb0655","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1001\/jamapediatrics.2020.6098","article-title":"Persistence of \u0394-9-tetrahydrocannabinol in human breast Milk","volume":"175","author":"Wymore","year":"2021","journal-title":"JAMA Pediatrics"},{"issue":"2","key":"10.1016\/j.pharmthera.2023.108468_bb0660","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/S0022-3565(24)38749-X","article-title":"Pre- or post-ischemic treatment with a novel Na+\/Ca2+ exchange inhibitor, KB-R7943, shows renal protective effects in rats with ischemic acute renal failure","volume":"296","author":"Yamashita","year":"2001","journal-title":"The Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.pharmthera.2023.108468_bb0665","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jchromb.2012.10.013","article-title":"High-throughput bioanalytical method for analysis of synthetic cannabinoid metabolites in urine using salting-out sample preparation and LC-MS\/MS","volume":"909","author":"Yanes","year":"2012","journal-title":"Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences"},{"issue":"7","key":"10.1016\/j.pharmthera.2023.108468_bb0670","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1021\/acs.molpharmaceut.2c00193","article-title":"Developing an in vitro to in vivo extrapolation (IVIVE) model to predict human milk-to-plasma drug concentration ratios","volume":"19","author":"Yang","year":"2022","journal-title":"Molecular Pharmaceutics"},{"key":"10.1016\/j.pharmthera.2023.108468_bb0675","article-title":"An in vitro human mammary epithelial cell permeability assay to assess drug secretion into breast milk","volume":"4","author":"Zhang","year":"2022","journal-title":"International Journal of Pharmaceutics: X"}],"container-title":["Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725823001328?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725823001328?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T22:32:28Z","timestamp":1759012348000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725823001328"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":134,"alternative-id":["S0163725823001328"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2023.108468","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potential neonatal toxicity of new psychoactive substances","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2023.108468","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108468"}}